Clinical Trial Update: Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating lenalidomide in older AML patients post-stem cell transplant; study terminated with results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome
• Acute Myeloid Leukemia in Remission

Drugs mentioned

• Lenalidomide (lenalidomide)

Snippet

Sponsor: Albert Einstein College of Medicine | Conditions: Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult Acute Myeloid Leukemia in Remission | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2020-05-14